Reported Earlier, BriaCell Therapeutics Prices $30M Public Offering Of 5,366,726 Units At $5.59 Per Unit To Fund Working Capital And Advance Immunotherapy Programs
Benzinga Newsdesk 9 months ago
NewsOfferings
Each Warrant is immediately exercisable, will entitle the holder to purchase one common share at an exercise price of $6.93 per share and will expire five years from the date of issuance.
Each Warrant is immediately exercisable, will entitle the holder to purchase one common share at an exercise price of $6.93 per share and will expire five years from the date of issuance.